Transfusion Medicine

Cerner Receives FDA Clearance for Cerner Bridge Transfusion Administration and Specimen Collections

Published in Blood Weekly, July 12th, 2007

Cerner Corp. (Nasdaq: CERN) announced that Cerner Bridge(TM) Transfusion Administration and Specimen Collections software solution has received U.S. Food and Drug Administration (FDA) 510(k) pre-market notification clearance. Cerner will immediately make this solution available to clients.

"Obtaining FDA 510(k) clearance for Cerner Bridge Transfusion Administration and Specimen Collections completes the point-of-care suite for Cerner Bridge Medical, which also includes Medication Administration," said Rick Neece, vice president for Cerner's Classic Solutions. "This is just another example of Cerner's commitment to point-of-care solutions and patient safety at the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2007-07-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry